Impact of gut probiotic metabolites on phenylketonuria. [PDF]
Kalla Veedu A +3 more
europepmc +1 more source
Phenylketonuria in adults: we know plenty, but there is much more to learn. [PDF]
Harding CO +15 more
europepmc +1 more source
The First 1000 Days of PKU: A Narrative Review of Maternal PKU and Early Life Management After Positive Newborn Screening. [PDF]
Verduci E +9 more
europepmc +1 more source
Current state of the treatment landscape of phenylketonuria. [PDF]
Nulmans I +4 more
europepmc +1 more source
Novel personalised drugs for infectious and conformational diseases
El panorama sanitario mundial se enfrenta a una crisis cada vez mayor: el desafío omnipresente de la resistencia a los antimicrobianos (AMR) y las bacterias multirresistentes (MDR).
Maity, Ritwik, Sancho Sanz, Javier
core
Performance of the Egoo test for phenylalanine measurement in females with phenylketonuria. [PDF]
Schoen MS, Nath SV, Singh RH.
europepmc +1 more source
Real-world pharmacovigilance insights into drug-induced risk of alopecia. [PDF]
Li H, Wei H, Shentu Q, Cui J, Chen J.
europepmc +1 more source
<i>In vivo</i> adenine base editing rescues brain biochemistry and improves motor deficits in a common phenylketonuria variant. [PDF]
Gautier MK +8 more
europepmc +1 more source
Advancing Gene Therapy for Phenylketonuria: From Precision Editing to Clinical Translation. [PDF]
Yu I, Jeong J.
europepmc +1 more source

